Holostem s.r.l.: Clinical Trials

6 trials sponsored by Holostem s.r.l., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated, 2 completed. 4 Phase 2, 3 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 13Terminated 3
Phase 31Terminated 1
Phase 41Completed 1

Follow Holostem s.r.l.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa
Transplantation - Junctional Epidermolysis Bullosa Non-Herlitz Type
Phase 2 / Phase 3TerminatedHolostem s.r.l.22022-07-152025-02-19
Clinical Trial to Assess the Safety and Efficacy of Investigational Product in Patients Due to Hypospadias Treatment Failure
"Ex vivo" expanded autologous human oral epithelium containing stem cells - Hypospadias
Phase 1 / Phase 2TerminatedHolostem s.r.l.12021-11-262024-11-12
Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17)
Transplantation surgery of genetically corrected cultured epidermal autograft (ATMP) - Junctional Epidermolysis Bullosa
Phase 1 / Phase 2TerminatedHolostem s.r.l.12018-03-192022-03-07
Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns
Ophthalmologic examinations, Digital pictures, QoL Questionnaires - Limbal Stem Cell Deficiency Due to Ocular Burn
CompletedHolostem s.r.l.472017-12-132023-05-26
Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB.
Genetically corrected cultured epidermal autograft (ATMP) - Recessive Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2TerminatedHolostem s.r.l.32017-01-302022-02-16
Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell Deficiency
Biopsy from donor eye, Implant of Holoclar, Ophtalmologic examination - Limbal Stem Cells Deficiency
Phase 4CompletedHolostem s.r.l.702015-10-012022-04-01

Conditions studied

Epidermolysis Bullosa Dystrophica (1)  ·  Epidermolysis Bullosa, Junctional (1)  ·  Epidermolysis Bullosa, Junctional, Non-Herlitz Type (1)  ·  Hypospadias (1)

Interventions

cyclic adenosine-5'-trimetaphosphate (2)  ·  Restraint, Physical (1)  ·  Surveys and Questionnaires (1)  ·  Transplantation (1)

Countries

Italy (4)  ·  Austria (2)  ·  France (1)

Top investigators

Graziella Pellegrini, Professor (3)  ·  Johann W. Bauer, MD (2)  ·  Michele De Luca, MD/Professor (2)  ·  Paolo Rama, MD (2)  ·  Cristina Magnoni, MD, Surgeon (1)  ·  Gianantonio Manzoni, MD (1)

NIH funding

2014 (1), 2015 (1)